Denmark vs Gambia: Hepatitis B surface antigen (HBsAg) prevalence
Denmark
0.1%
in 2024
Gambia
0.1%
in 2024
Denmark rank
101st
Gambia rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Denmark
- Gambia
How they compare
Denmark currently reports 0.1% against 0.1% in Gambia, a difference of 0.0%.
Across all 10 years both countries report, Gambia has been ahead every year.
Denmark ranks 101st and Gambia ranks 101st of 194 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.1% | Gambia |
| 2020s | 0.1% | 0.2% | 0.1% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Denmark or Gambia?
- Denmark, at 0.1% against 0.1% in Gambia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Denmark and Gambia?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Gambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Gambia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Denmark ranks 101st and Gambia ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.